The overlap between vascular disease and Alzheimer's disease--lessons from pathology

Johannes Attems1, Kurt A Jellinger

  • 1Institute of Neuroscience, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, NE4 5PL, UK. j.attems@ncl.ac.uk.

BMC Medicine
|November 12, 2014
PubMed

Insights

Cerebrovascular disease (CVD) and Alzheimer's disease (AD) often coexist, accelerating cognitive decline. Early-stage AD combined with cerebrovascular lesions lowers the dementia threshold.

Area of Science:

  • Neurology
  • Pathology
  • Epidemiology

Background:

  • Epidemiological and clinico-pathological data reveal significant overlap between cerebrovascular disease (CVD) and Alzheimer's disease (AD).
  • Cerebral amyloid angiopathy and small vessel disease are common vascular pathologies in aging brains and AD.
  • Up to 84% of aged individuals exhibit morphological signs of CVD alongside AD pathology.

Purpose of the Study:

  • To investigate the additive or synergistic effects of comorbid CVD and AD pathologies on cognitive decline.
  • To examine the impact of different types and severities of CVD on cognitive impairment in AD.

Main Methods:

  • Analysis of epidemiological data and clinico-pathological findings in aging brains and AD patients.
  • Classification of dementia types based on the presence and severity of AD and CVD pathologies.
  • Correlation of specific vascular lesions (subcortical lesions, infarcts) with cognitive status.

Main Results:

  • In advanced AD, small infarcts do not significantly impact cognition due to the overwhelming AD pathology.
  • In early AD stages, cerebrovascular lesions can exacerbate cognitive impairment and lower the threshold for dementia.
  • Mixed dementia (AD + CVD) frequently presents with multiple larger infarcts, unlike pure vascular dementia.

Conclusions:

  • Comorbid CVD and AD have significant, often synergistic, effects on cognitive decline.
  • The impact of CVD on cognitive impairment is stage-dependent in Alzheimer's disease.
  • Further research is needed to fully understand the interplay between CVD and AD in dementia development and progression.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
7
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
4
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
6
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
6